Literature DB >> 16461930

Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1.

M L Panno1, L Mauro, S Marsico, D Bellizzi, P Rizza, C Morelli, M Salerno, F Giordano, S Andò.   

Abstract

In the present study, the molecular mechanism underlying the up-regulatory effect of estradiol (E2) on mouse insulin receptor substrate-1 (IRS-1) promoter was investigated in CHO cells on which the same promoter had first been functionally characterized. The mouse IRS-1 promoter bears four consensus half Estrogen Responsive Elements (ERE) sequences and thirteen AP-1- and ten Sp1-binding elements. We performed molecular dissection of this promoter gene providing 3' different deleted constructs, containing the same AP-1 rich region with a progressively increased number of ERE half sites located downstream. None of these constructs was responsive to E2, while a downstream region (nt -1420 to -160) rich in GC elements was induced by E2. However, the latter region lost its intrinsic E2 responsiveness when the whole IRS-1 promoter was mutated for deletion in all four ERE half sites. Deletion analysis of the ERE half sites demonstrated that only ERE located at the position -1500 to -1495, close to the GC-rich region, was able to maintain the induced activatory effect of E2 on the IRS-1 gene. Electrophoretic mobility shift and chromatin immunoprecipitation assays identified the region containing the half ERE/Sp1 (nt -1500 to -1477) as the one conferring E2 responsiveness to the whole promoter. This effect occurs through the functional interaction between E2/ERalpha and Sp1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461930     DOI: 10.1677/jme.1.01848

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  7 in total

1.  Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.

Authors:  V Bartella; P Rizza; I Barone; D Zito; F Giordano; C Giordano; S Catalano; L Mauro; D Sisci; M L Panno; S A W Fuqua; S Andò
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

2.  Significance of estrogen receptor subtypes in breast tumorigenesis and progression.

Authors:  Weiliang Sun; Chijiang Gu; Minming Xia; Guoping Zhong; Haojun Song; Junming Guo
Journal:  Tumour Biol       Date:  2014-06-11

3.  Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma.

Authors:  Clifford J Cookman; Scott M Belcher
Journal:  Endocrinology       Date:  2015-04-17       Impact factor: 4.736

Review 4.  Actions of Steroids: New Neurotransmitters.

Authors:  Lauren M Rudolph; Charlotte A Cornil; Melinda A Mittelman-Smith; Jennifer R Rainville; Luke Remage-Healey; Kevin Sinchak; Paul E Micevych
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

5.  PI3K: An Attractive Candidate for the Central Integration of Metabolism and Reproduction.

Authors:  Maricedes Acosta-Martínez
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-24       Impact factor: 5.555

6.  IL-4 and IL-13 Promote Proliferation of Mammary Epithelial Cells through STAT6 and IRS-1.

Authors:  Wan-Ju Wu; Sue-Hong Wang; Chun-Chi Wu; Yi-An Su; Chin-Yin Chiang; Ching-Hong Lai; Tsung-Hsiang Wang; Tsung-Lin Cheng; Jia-Yu Kuo; Tsai-Ching Hsu; Ting-Hui Lin; Yi-Ju Lee
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

7.  Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.

Authors:  Pietro Rizza; Ines Barone; Domenico Zito; Francesca Giordano; Marilena Lanzino; Francesca De Amicis; Loredana Mauro; Diego Sisci; Stefania Catalano; Karin Dahlman Wright; Jan-Ake Gustafsson; Sebastiano Andò
Journal:  Breast Cancer Res       Date:  2014-02-19       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.